Abstract
Ototoxicity is a well-known side effect of cisplatin. Some genetic and non-genetic risk factors were described for cisplatin ototoxicity. Although there are some studies which point out a sex-related difference for cisplatin nephrotoxicity and neurotoxicity, sex-related differences for cisplatin ototoxicity have not been studied. The aim of this study is to reveal whether there is any gender-related difference for susceptibility to cisplatin ototoxicity in rats. Fourteen male, 14 female Wistar albino rats were divided into four groups; a female control, a male control, a female cisplatin and a male cisplatin group. Distortion Product Otoacoustic Emission and, Auditory Brainstem Response measurements were obtained. For the cisplatin groups 16 mg/kg of cisplatin was applied. On the 4th day audiological examinations were repeated. After killing, cochleae and brainstem tissues were evaluated by light and electron microscopy. The hearing of the female rat cisplatin group was found to have deteriorated more than the hearing of the male rat cisplatin group. Histopathological evaluation revealed more serious damage in the spiral ganglion and brainstem tissues of female rats. Hearing of female rats deteriorated more than the hearing of male rats upon application of cisplatin. This difference in hearing can be attributed to the more severe damage seen in neuronal tissues such as spiral ganglion cells and brainstem neurons.
Similar content being viewed by others
References
Wongtawatchai T, Agthong S, Kaewsema A, Chentanez V (2009) Sex related differences in cisplatin- induced neuropathy in rats. J Med Assoc Thai 92:1485–1491
Aydın I, Agilli M (2014) Aydin FN gender differences influences renal injury in cisplatin- treated rats: biochemical evaluation. Biol Trace Elem Res 158:275. doi:10.1007/S12011-014-9945-3
Jazi FE, Nematbakhsh M, Pezeshkin Z et al (2013) Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats. Iran J Kidney Dis 7:383–389
Olgun Y, Kırkım G, Kolatan E et al (2014) Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. Laryngoscope 124:760–766
Güneş D, Kırkım G, Kolatan E et al (2011) Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity. Chemotherapy 57(3):186–194
Olgun Y, Kırkım G, Kolatan E (2013) Otoprotective effect of recombinant human erythropoietin in a model of newborn hypoxic-ischemic encephalopathy. Int J Pediatr Otorhinolaryngol 77:739–746
Nicolson TJ, Mellor HR, Roberts RR (2010) Gender differences in drug toxicity. Trends Pharmacol Sci 31(3):108–114
Gochfeld M (2007) Framework for gender differences in human and animal toxicology. Environ Res 104:4–21
Beirle I, Meibohm B, Derendorf H (1999) Gender Differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther 37:529–547
Wang J, Huanf Y (2007) Pharmocogenomics of Sex Difference in Chemotherapeutic Toxicity. Curr Drug Discov Technol 4:59–68
Franconi F (2007) Brunelleschi, Stardo L, Cuomo V. Gender differences in drug responses. Pharmacol Res 55:81–95
Langer T, Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O (2013) Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 1059:1–12
Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J of Cancer 40:2445–2451
Yancey A, Haris MS, Egbelakin A et al (2012) Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients. Pediatr Blood Cancer 9:144–148
Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL (2007) Ototoxicity from cisplatin therapy in childhood cancer. J Pediatr Hematol Oncol 29(6):355–360
Olgun Y (2013) Cisplatin ototoxicity: where we are? Int Adv Otol 9(3):395–408
Wei Q et al (2005) Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol 25:491–499
Lu Y, Kawashima A, Horii I, Zhong L (2005) Cisplatin induced cytotoxicity in BSO-exposed renal proximal tubular epithelial cells: sex, age and species. Ren Fail 27(5):629–633
Pezeshki Z, Nematbakhsh M, Ashrafi F (2013) Evidence against protective role of sex hormone estrogen in cisplatin-induced nephrotoxicity in ovarectomized rat model. Toxicol Int 20(1):43–47
Stakisaitis D, Dudeniene G, Jankūnas RJ, Grazeliene G, Didziapetriene J, Pundziene B (2010) Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina (Kaunas) 46(1):45–50
Shabani M, Larizadeh MH, Parsania S, Hajali V, Shojaei A (2012) Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance. Int J Neurosci 8:439–448
Im GJ, Chang JW, Choi J, Chae W, Ko EJ, Jung HH (2010) Protective effect of korean red gingsenf extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytothrer Res 24:614–621
Riga MG, Chelis L, Kakolyris S et al (2004) Prevention of cisplatin ototoxicity using transtympanic N- acetylcysteine and lactate. Otol Neurootol 25:910–915
Acknowledgments
This study was financially supported by a grant from Dokuz Eylul University Research Foundation.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kirkim, G., Olgun, Y., Aktas, S. et al. Is there a gender-related susceptibility for cisplatin ototoxicity?. Eur Arch Otorhinolaryngol 272, 2755–2763 (2015). https://doi.org/10.1007/s00405-014-3283-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3283-0